CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $4.06 ($20,275)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Results of operations · Other events
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at $13.79 ($27,580)
- 4 Open-market buy Director bought 1,000 shares at $12.60 ($12,600)
- 8-K Event Executive or director change · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure · Other events
- 4 Other acquisition Chief Financial Officer acquired 1,453 shares (other)
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 1 of 76 · 1,519 filings